Skip to main content
. 2012 Apr 3;12:83. doi: 10.1186/1471-2334-12-83

Figure 3.

Figure 3

Cost-effectiveness acceptability curve; probability that posaconazole is cost-effective relative to SAT (standard azole treatment; fluconazole or itraconazole).